Clinical trial

Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC

NCT04189094

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2020-01-01

PhasePHASE2

Study timeline

Study start (estimated)2020-01-01Date precision: day

Registry last updated2019-12-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small Cell Lung Cancer Limited Stageunresolved

Interventions

EtoposideDRUG · verified · RxNorm: etoposide

CisplatinDRUG · verified · RxNorm: cisplatin

radiotherapyRADIATION

Sponsors & collaborators

Zhejiang Cancer Hospitallead sponsor

First Affiliated Hospital, Sun Yat-Sen Universitycollaborator

Affiliated Hospital of Guangdong Medical Universitycollaborator

First People's Hospital of Foshancollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04189094 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.